Generate Biomedicines surges again, rises 12% to new high (GENB:NASDAQ)
· seekingalpha.com
GENB stock jumps to a new 52-week high—see key levels, RSI, volume, short interest, and Phase 3 GB-0895 updates plus analyst takeaways.
Shares of Generate Biomedicines (GENB), an AI-driven drug discovery company, advanced about 12% today. Shares traded at $19.81 in mid-afternoon trading, a gain ...